51 – 60 of 123
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Development and external validation of a prognostic model in newly diagnosed Parkinson disease
(
- Contribution to journal › Article
-
Mark
Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells
(
- Contribution to journal › Article
-
Mark
Atomoxetine restores the response inhibition network in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
(
- Contribution to journal › Article
-
Mark
Variation in Recent Onset Parkinson's Disease : Implications for Prodromal Detection
(
- Contribution to journal › Article
-
Mark
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
(
- Contribution to journal › Article
-
Mark
A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Statins are underused in recent-onset Parkinson's disease with increased vascular risk : findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
(
- Contribution to journal › Article
-
Mark
Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
(
- Contribution to journal › Article